Loading...
01/10 16:00
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlighted significant improvements in financial performance, including the first annual operating profit and positive cash flow, driven by reduced expenses and enhanced efficiency. Despite a slight revenue decline, management's optimistic guidance and strategic focus on AI and digital transformation support a positive outlook. The Q&A revealed confidence in sustained profitability and cost optimization, although some responses lacked clarity. Overall, the positive financial turnaround and strategic initiatives suggest a positive stock price movement, offsetting concerns about unclear partnership plans.
Total Net Revenues (Q4 2024) RMB3.8 billion, decreased by 6.3% year-over-year due to unfavorable macroeconomic conditions.
Gross Segment Profit (Q4 2024) RMB202.5 million, decreased by 5.5% year-over-year due to the same unfavorable macroeconomic environment.
Total Operating Expenses (Q4 2024) RMB209.8 million, decreased by 50.1% year-over-year, accounting for 5.5% of net revenues, down from 10.2% due to enhanced operating leverage and efficiency.
Fulfillment Expenses (Q4 2024) 2.7% of net revenues, slightly increased from 2.5% in the prior year.
Sales and Marketing Expenses (Q4 2024) 2% of net revenues, down from 4.2% a year earlier.
G&A Expenses (Q4 2024) 0.5% of net revenues, down from 2.4% in the previous year.
Technology Expenses (Q4 2024) 0.4% of net revenues, down from 1.2% in the same quarter 2023.
Non-GAAP Loss on Operations (Q4 2024) RMB2.3 million, improved by 95.8% from RMB55.2 million in the prior year.
Non-GAAP Net Loss Attributable to Ordinary Shareholders (Q4 2024) RMB14.8 million, improved by 74.9% from RMB59 million in the previous year.
Full Year 2024 Net Revenues RMB14.4 billion, decreased by 3.7% year-over-year.
Full Year 2024 Gross Segment Profit RMB829.2 million, decreased by 2.3% year-over-year.
Full Year 2024 Total Operating Expenses RMB827.1 million, decreased by 31% year-over-year, accounting for 5.7% of net revenues, down from 8%.
Fulfillment Expenses (Full Year 2024) 2.6% of net revenues, slightly decreased from 2.7% in the previous year.
Sales and Marketing Expenses (Full Year 2024) 2.2% of net revenues, down from 3% in 2023.
G&A Expenses (Full Year 2024) 0.5% of net revenues, down from 1.5% a year earlier.
Technology Expenses (Full Year 2024) 0.5% of net revenues, down from 0.8% in 2023.
Income from Operations (Full Year 2024) RMB2.1 million, compared to a loss of RMB351 million in 2023.
Non-GAAP Income from Operations (Full Year 2024) RMB22.3 million, compared to a loss of RMB123.9 million in 2023.
GAAP Net Loss Attributable to Ordinary Shareholders (Full Year 2024) 0.3% of net revenues, improved from 1.1% a year ago.
Cash Position (as of December 31, 2024) RMB518.3 million in cash and cash equivalents, restricted cash, and short-term investments.
Operating Cash Flow (Full Year 2024) Positive operating cash flow for the first time, amounting to RMB263 million.
New Product Introductions: In 2024, the broadband catalog introduced 6,598 new products contributing over RMB905 million in GMV.
Market Expansion: Expanded last mile delivery coverage to additional metropolitan areas including Wuhan, Guangzhou, Chongqing and Tianjin.
Fulfillment Center Expansion: Added seven new fulfillment centers in Q4, increasing total to 18, enabling delivery to over 300 major cities within 24 hours.
Operational Efficiency: Achieved first ever operational profitability with income from operations reaching RMB2.1 million, a turnaround from a loss of RMB350.1 million in 2023.
Cost Reduction: Total operating expenses decreased by 31% year-over-year, down to 5.7% of revenues.
Technology Investments: Strengthened digital capabilities with investments in system development, advanced models, algorithms, and data applications.
Strategic Shift: Focus on AI-driven digital transformation to enhance operational efficiency and customer engagement.
Supply Chain Strategy: Initiated the Kunpeng Network to streamline logistics services and reduce costs.
Macroeconomic Pressures: Economic uncertainties in China have led to cautious consumer behavior, slowing discretionary spending, and dampening retail sales growth, impacting the healthcare sector.
Healthcare Reforms: Ongoing healthcare reforms, including adjustments to medical accounts and regulatory oversight, present short-term challenges as the industry adapts to new policies.
Market Competition: Increased competition due to aggressive expansion during the pandemic has resulted in a decline in retail pharmacy sales, with revenues per store falling.
Profitability Challenges: Newer stores in growth phases face pressure on short-term profitability, with significant declines in net profits reported by major pharmacy chains.
Digital Transformation Necessity: Pharmacies must cope with weaker consumer sentiment and operational inefficiencies, making digital transformation essential for survival and growth.
Regulatory Uncertainties: Policy execution remains uneven across provinces, leading to uncertainties and delays in medical reform implementation.
Investor Redemption Requests: The company has received redemption requests from investors, leading to negotiations for phased repayments, which could impact cash flow.
Arbitration Outcome: An arbitration ruling requiring the company to repurchase shares for RMB30 million plus interest may pose financial implications.
Operational Profitability: Achieved first-ever operational profitability and positive operating cash flow in 2024.
Cost Reduction: Reduced total operating expenses by 50.1% year-over-year, bringing them to 5.5% of revenues.
Digital Transformation: Integrated leading technologies across operations to enhance efficiency and service quality.
Supply Chain Infrastructure: Strengthened supply chain infrastructure to better meet future demand with lower costs.
Kunpeng Network: Expanded logistics network to streamline services and lower costs, with plans for further fulfillment center additions.
AI Integration: Invested in AI technologies to enhance demand forecasting and operational efficiency.
Revenue Outlook: Despite challenges, the company remains optimistic about long-term growth in China's healthcare market.
Future Investments: Plans to expand fulfillment centers by adding at least 15 more centers in 2025.
Customer Engagement Initiatives: Continued focus on high-impact initiatives to stimulate customer engagement and loyalty.
Operational Efficiency: Commitment to driving operational efficiency as a critical factor for success in a competitive market.
Financial Projections: Expectations for continued improvements in profitability and operational performance.
Shareholder Return Plan: The company has reached agreements with investors representing approximately 97% of the total amount owed to reschedule repayments, allowing for phased repayments over extended periods.
Share Repurchase: The company has already paid a portion of the repurchase of funds upon signing the agreement.
Redemption Request: In January 2025, the company was required to repurchase investment shares for RMB30 million plus accrued interest.
The earnings call presents a mixed outlook. While the company achieved its first operating profit and improved cash flow, revenues and gross profit declined, and there are concerns over macroeconomic impacts. The Q&A highlights positive operational changes but lacks clarity on AI investments. The share repurchase ruling could strain cash flow. Despite cost reductions and strategic plans for growth, the absence of strong revenue growth or new partnerships tempers the outlook. Without market cap data, a neutral sentiment is prudent.
The earnings call highlighted significant improvements in financial performance, including the first annual operating profit and positive cash flow, driven by reduced expenses and enhanced efficiency. Despite a slight revenue decline, management's optimistic guidance and strategic focus on AI and digital transformation support a positive outlook. The Q&A revealed confidence in sustained profitability and cost optimization, although some responses lacked clarity. Overall, the positive financial turnaround and strategic initiatives suggest a positive stock price movement, offsetting concerns about unclear partnership plans.
The earnings call reflects a mixed sentiment. While there are positive aspects like operational profitability, improved gross profit margins, and positive cash flow, there are significant challenges such as macroeconomic pressures, regulatory issues, and flat revenue growth. The Q&A section indicates optimism but lacks clarity in some responses. The strategic partnership and investment in technology are positives, but the economic uncertainties and outstanding liabilities pose risks. Overall, the sentiment is neutral with a potential slight positive tilt due to operational improvements and strategic initiatives.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
